Podcast Episodes
Back to SearchIs It Time for a New Type of Cancer Physician?
Episode 32
The dramatic increase in cancer survivorship is introducing questions about the ability of physicians to meet patient needs. “Maybe we need to have a…
17 hours ago
What the “Tsunami” of Cancer Survivors Means for Oncologists
Episode 33
Advances in cancer treatments have led to a rising “tsunami” of survivors, which has introduced a new set of challenges for oncologists. Saro H. Arme…
1 month ago
“Sobering” Takeaway From ASCO 2026: Concerns About Clinical Trial Participation
Episode 34
Amid the exciting advances at ASCO 2026, there came a “sobering moment” regarding the U.S.’s role as a cancer clinical trial leader, says Robert A. W…
1 month, 3 weeks ago
“A Lot More Asymptomatic Cancer Out There”: Major MCED Trial Hints at Complicated Future
Episode 31
The prospective randomized NHS-Galleri multicancer early detection trial didn’t meet its primary endpoint, but it did uncover a lot more early-stage …
1 month, 4 weeks ago
“The Ever-Shifting and Chaotic” State of CLL Care: What New Data Mean for Practice
Episode 30
Data presented at the 2026 American Society of Clinical Oncology Annual Meeting add to the “ever-shifting and chaotic space” that is CLL care, says M…
1 month, 4 weeks ago
How “Drastically Better” Treatments for Some Colorectal Cancers Are Changing Care
Episode 29
New treatments for patients with microsatellite instability–high colorectal cancer are drastically changing outcomes. Nicholas James Hornstein, MD, P…
2 months ago
“Not a Straightforward Decision”: What to Do While Waiting on a Practice Change in Breast Cancer Care
Episode 28
In the wake of recent key data about ESR1-mutated metastatic breast cancer, treatment decisions have become more complicated. “In current clinical pr…
3 months, 3 weeks ago
New Targeted Therapies Make Breast Cancer Treatment Decisions “a Bit of a Moving Target”
Episode 27
“In breast cancer now, all of our treatment for hormone receptor–positive metastatic
disease is a bit of a moving target because of new therapies tha…
4 months ago
Advances in ESR1-Mutated Breast Cancer Care Lead to “Complex Situation” in Clinic
Episode 26
As the management of patients with ESR1-mutated metastatic breast cancer evolves,
various questions have emerged in clinical practice. “It's a comple…
4 months ago
Tackling “the Biggest Question That Everyone Is Asking” in Breast Cancer Care
Episode 25
How are oncologists currently approaching the care of patients with ESR1-mutated advanced breast cancer in practice? Erin Frances Cobain, MD, associa…
4 months, 2 weeks ago